BEVERLY HILLS, Calif.--(BUSINESS WIRE)--The Cardiovascular Research Foundation of Southern California (CVRF) - a non-profit charitable organization committed to supporting and conducting innovative ...
News-Medical.Net on MSN
See through the skin: New technology spots early heart disease warning signs
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed "fast-RSOM", a new imaging technology that can capture detailed images of the smallest blood vessels ...
A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels — a quiet warning ...
New Delhi: German researchers have developed a new non-invasive imaging technology that can scan the skin and detect early warning signs of cardiovascular disease, potentially enabling earlier ...
A team of German researchers has developed a new imaging technology that can noninvasively scan your skin and also reveal ...
Corify Care introduces whole-heart mapping technology, delivering a global view of cardiac Arrhythmias in a single beat: Madrid Friday, January 30, 2026, 11:00 Hrs [IST] Corify Ca ...
Medical Device Network on MSN
Intuitive receives FDA clearance for non-force feedback instruments in cardiac procedures
Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...
TCT 1175: Trans-septal Stabilization of Guide Wire to Facilitate Delivery of Arch Endograft in a Patient With Giant Tortuous Thoracic Aortic Aneurysm Receive the the latest news, research, and ...
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...
PolyVascular, a medtech company developing a non-surgical heart valve for children with congenital heart disease, has obtained $2 million in funding from non-profit pediatric initiative, CobiCure ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results